These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29273831)

  • 1. Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus.
    Tanhapour M; Miri A; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Pourmotabbed T; Shakiba E
    Clin Rheumatol; 2018 Apr; 37(4):971-977. PubMed ID: 29273831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase (PON1) 55 polymorphism and association with systemic lupus erythematosus.
    Bahrehmand F; Vaisi-Raygani A; Ahmadi R; Kiani A; Rahimi Z; Tavilani H; Pourmotabbed T
    Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):211-9. PubMed ID: 23893804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.
    Ibrahim AA; El-Lebedy D; Ashmawy I; Hady MA
    Clin Rheumatol; 2017 Jun; 36(6):1305-1310. PubMed ID: 28185016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Ardalan M; Vaisi-Raygani H; Shakiba E; Pourmotabbed T
    Lupus; 2015 May; 24(6):597-605. PubMed ID: 25416694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between activity and genotypes of paraoxonase1 L
    Tanhapour M; Shahmohamadnejad S; Vaisi-Raygani A; Kiani A; Shakiba Y; Rahimi Z; Bahrehmand F; Shakiba E; Vaisi-Raygani AA; Alibakhshi R; Eivazi A; Pourmotabbed T
    Mol Biol Rep; 2019 Feb; 46(1):741-749. PubMed ID: 30506510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus.
    Dasgupta S; Demirci FY; Dressen AS; Kao AH; Rhew EY; Ramsey-Goldman R; Manzi S; Kammerer CM; Kamboh MI
    BMC Med Genet; 2011 Jan; 12():7. PubMed ID: 21223581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin type 1 receptor A1166C polymorphism and systemic lupus erythematosus: correlation with cellular immunity and oxidative stress markers.
    Baniamerian H; Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Pourmotabbed T
    Lupus; 2017 Dec; 26(14):1534-1539. PubMed ID: 28530466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
    Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of L55M and Q192R polymorphisms of paraoxonase-1 gene with preeclampsia.
    Yaghmaei M; Hashemi M; Azarian A; Moazeni-Roodi A; Mokhtari M; Naghavai A; Salimi S; Mohammadi M; Taheri M; Ghavami S
    Arch Med Res; 2011 May; 42(4):324-8. PubMed ID: 21820612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
    Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
    Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
    Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
    Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
    Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
    Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphisms in the genes of cytochrome oxidase P450 2D6 (CYP2D6), paraoxonase 1 (PON1) and apolipoprotein E (APOE) as risk factors for Parkinson's disease].
    Durić G; Svetel M; Nikolaevic SI; Dragadević N; Gavrilović J; Kostić VS
    Vojnosanit Pregl; 2007 Jan; 64(1):25-30. PubMed ID: 17304721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the cytotoxic T-lymphocyte antigen-4 mutations and the susceptibility to systemic lupus erythematosus; Contribution markers of inflammation and oxidative stress.
    Tanhapour M; Vaisi-Raygani A; Bahrehmand F; Khazaei M; Kiani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
    Cell Mol Biol (Noisy-le-grand); 2016 Oct; 62(12):56-61. PubMed ID: 27894401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus.
    Kiss E; Seres I; Tarr T; Kocsis Z; Szegedi G; Paragh G
    Ann N Y Acad Sci; 2007 Jun; 1108():83-91. PubMed ID: 17893973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of angiotensin-converting enzyme (ACE) I/D variation with biochemical parameters and oxidative stress markers in systemic lupus erythematosus patients in west of Iran.
    Kiani A; Elieh-Ali-Komi D; Bahrehmand F; Mostafaei S; Vaisi-Raygani A; Baniamerian H; Aghaz F; Tanhapour M; Shakiba E; Rahimi Z; Pourmotabbed T
    Mol Biol Rep; 2023 Oct; 50(10):8201-8212. PubMed ID: 37561325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.